CENTURY THERAPEUTICS INC (IPSC) Stock Earnings & Estimates
USA - NASDAQ:IPSC - US15673T1007 - Common Stock
0.5601 USD
-0.01 (-2.25%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.2M | 2.235M -57.02% | 6.589M 194.81% | 111.35M 1,589.94% | -100.00% | 10.883M | 39.77M 265.43% | |||||
| EBITDA YoY % growth | -115.39M -26.62% | -112.137M 2.82% | -120.506M -7.46% | -143.942M -19.45% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -123.83M -30.51% | -125.181M -1.09% | -133.81M -6.89% | -26.002M 80.57% | -118.04M -353.97% | -128.535M -8.89% | -186.66M -45.22% | 46.92M 125.14% | 271.32M 478.26% | 650.76M 139.85% | N/A | |
| Operating Margin | -2,381.35% | -5,600.94% | -2,030.81% | -23.35% | N/A | N/A | N/A | N/A | N/A | 5,979.60% | N/A | |
| EPS YoY % growth | -2.28 30.47% | -2.29 -0.44% | -1.63 28.82% | -0.11 92.96% | -1.27 -1,004.44% | -1.42 -11.87% | -1.31 7.91% | 0.09 107.03% | 1.53 1,566.67% | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.34 6.96% | -0.29 31.80% | -0.28 -131.71% | -0.29 23.95% | -0.36 -5.93% | -0.36 -24.35% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -31.485M 9.50% | -27.377M 16.93% | -30.728M -141.43% | -31.62M 8.78% | -26.52M 15.77% | -27.795M -1.53% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.38 | -0.38 | 0.00 | 0.92% |
| Q1 2025 Q2Q % growth | 0.89 297.78% | 0.06 | 0.83 | 1,486.45% |
| Q4 2024 Q2Q % growth | -0.43 33.85% | -0.43 | 0.00 | 0.10% |
| Q3 2024 Q2Q % growth | -0.37 32.73% | -0.46 | 0.09 | 19.03% |
| Q2 2024 Q2Q % growth | -0.38 32.14% | -0.47 | 0.09 | 19.26% |
| Q1 2024 Q2Q % growth | -0.45 15.09% | -0.51 | 0.06 | 12.12% |
| Q4 2023 Q2Q % growth | -0.65 -18.18% | -0.57 | -0.08 | -14.97% |
| Q3 2023 Q2Q % growth | -0.55 -3.77% | -0.52 | -0.03 | -5.20% |
| Q2 2023 Q2Q % growth | -0.56 -3.70% | -0.56 | 0.00 | -0.88% |
| Q1 2023 Q2Q % growth | -0.53 19.70% | -0.53 | 0.00 | 0.73% |
| Q4 2022 Q2Q % growth | -0.55 -129.17% | -0.60 | 0.05 | 9.01% |
| Q3 2022 Q2Q % growth | -0.53 -10.42% | -0.61 | 0.08 | 12.65% |
| Q2 2022 Q2Q % growth | -0.54 72.02% | -0.53 | -0.01 | -2.60% |
| Q1 2022 Q2Q % growth | -0.66 | -0.46 | -0.20 | -43.00% |
| Q4 2021 Q2Q % growth | -0.24 | -0.49 | 0.25 | 50.72% |
| Q3 2021 Q2Q % growth | -0.48 | -0.41 | -0.07 | -17.65% |
| Q2 2021 Q2Q % growth | -1.93 | -0.43 | -1.50 | -354.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | % | ||
| Q1 2025 Q2Q % growth | 109.164M 12,667.72% | 50.541M | 58.623M | 115.99% |
| Q4 2024 Q2Q % growth | 4.173M 1,457.09% | 956.76K | 3.216M | 336.16% |
| Q3 2024 Q2Q % growth | 791K 434.46% | 2.064M | -1.273M | -61.68% |
| Q2 2024 Q2Q % growth | 771K 678.79% | 1.97M | -1.199M | -60.86% |
| Q1 2024 Q2Q % growth | 855K -50.29% | 1.287M | -432K | -33.57% |
| Q4 2023 Q2Q % growth | 268K -48.46% | 1.874M | -1.606M | -85.70% |
| Q3 2023 Q2Q % growth | 148K -93.33% | 1.185M | -1.037M | -87.51% |
| Q2 2023 Q2Q % growth | 99K -92.93% | 1.164M | -1.065M | -91.49% |
| Q1 2023 Q2Q % growth | 1.72M 62.26% | 1.336M | 384K | 28.74% |
| Q4 2022 Q2Q % growth | 520K | 2.009M | -1.489M | -74.12% |
| Q3 2022 Q2Q % growth | 2.22M | 1.151M | 1.069M | 92.88% |
| Q2 2022 Q2Q % growth | 1.4M | 975.559K | 424.441K | 43.51% |
| Q1 2022 Q2Q % growth | 1.06M | 5.1M | -4.04M | -79.22% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 11.57% | 0% | 58.59% |
| Revenue | N/A | N/A | 0% | -0.01% |